Skip to main content
Government Resource

Public Meeting on Improving Patient Safety by Enhancing the Container Labeling for Parenteral Infusion Drug Products.

Food and Drug Administration; FDA; Department of Health and Human Services; HHS

Save

Print

January 31, 2007
Food and Drug Administration; FDA; Department of Health and Human Services; HHS

The US Food and Drug Administration invited experts to comment on how labels for intravenous drugs could be designed to ensure the safe use of these medications through informed label redesign efforts.